Tokorozawa, Japan

Manabu Kaneda

This inventor holds 4 USPTO granted patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manabu Kaneda. Retrieved from https://idiyas.com/inventor/manabu-kaneda-ap1k4tz8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Manabu Kaneda: Innovator in Bicyclolactam Compounds

Introduction

Manabu Kaneda is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of bicyclolactam compounds. With a total of 4 patents to his name, Kaneda's work has implications for various applications in pharmaceuticals.

Latest Patents

Kaneda's latest patents focus on bicyclolactam compounds, their uses, and the intermediates for preparing them. These innovations are crucial for advancing pharmaceutical research and development.

Career Highlights

Kaneda is currently employed at Taiho Pharmaceutical Company Limited, where he continues to push the boundaries of chemical research. His expertise in bicyclolactam compounds has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Kaneda has collaborated with esteemed colleagues such as Junji Yamamoto and Takashi Arima. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Manabu Kaneda's contributions to the field of chemistry, particularly through his patents on bicyclolactam compounds, highlight his role as an influential inventor. His work at Taiho Pharmaceutical Company Limited continues to impact the pharmaceutical landscape significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…